There is a growing understanding that the early phases of type 1 diabetes (T1D) are
characterised by a deleterious dialogue between the pancreatic beta cells and the immune …

ABSTRACT Introduction Type 1 diabetes (T1D) is an autoimmune disease in which pro-
inflammatory and cytotoxic signaling drive the death of the insulin-producing β cells. This …

Type 1 diabetes (T1D) is a chronic disease that is usually diagnosed in childhood,
underscoring the importance of early disease control for overall wellbeing. Our aim was to …

Abstract Purpose of the Review Current global information on incidence, prevalence, and
mortality of type 1 diabetes (T1D) is limited, particularly in low-and middle-income countries …

Patients with diabetes have a high risk of developing skeletal diseases accompanied by
diabetic peripheral neuropathy (DPN). In this study, we isolated the role of DPN in skeletal …

Type 1 diabetes (T1D) is one of the most common chronic autoimmune diseases,
characterized by absolute insulin deficiency caused via inflammatory destruction of the …

Introduction The purpose of this retrospective clinic chart review study was to determine the
potential of a combination therapy (CT) consisting of γ-aminobutyric acid (GABA), a …

Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at
the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay …

BACKGROUND: Type 1 diabetes (T1D) is a major cause of endothelial dysfunction.
Although cellular bioenergetics has been identified as a new regulator of vascular function …

By reducing carbohydrate intake, people with type 1 diabetes may reduce fluctuations in
blood glucose, but the evidence in this area is sparse. The aim of this study was to …